Diseases, Conditions, Syndromes
Nintedanib plus sildenafil no better than nintedanib in IPF
(HealthDay)—Nintedanib plus sildenafil does not provide benefit over nintedanib alone for patients with idiopathic pulmonary fibrosis (IPF) and diffusion capacity of the lungs for carbon monoxide (DLCO) of 35 percent or ...
Sep 28, 2018
0
0